☰

Tulin H. Dadali, Ph.D. - Publications

Affiliations: 
2014 School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
Cell Biology, Biochemistry, Pathology
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Dadali T, Diers AR, Kazerounian S, Muthuswamy SK, Awate P, Ng R, Mogre S, Spencer C, Krumova K, Rockwell HE, McDaniel J, Chen EY, Gao F, Diedrich KT, Vemulapalli V, et al. Elevated levels of mitochondrial CoQ induce ROS-mediated apoptosis in pancreatic cancer. Scientific Reports. 11: 5749. PMID 33707480 DOI: 10.1038/s41598-021-84852-z  0.346
2020 Schultz MD, Dadali T, Jacques SA, Muller-Steffner H, Foote JB, Sorci L, Kellenberger E, Botta D, Lund FE. Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival. Plos Pathogens. 16: e1008539. PMID 32459815 DOI: 10.1371/Journal.Ppat.1008539  0.503
2018 Dadali T, Kulkarni S, Ng R, Awate P, Mogre S, Diers AR, Jang T, Merchant M, Sun J, Gesta S, Thapa K, Nagpal S, Recht L, Narain NR, Sarangarajan R. Abstract 873: BPM 31510, a clinical stage metabolic modulator, demonstrates therapeutic efficacy in glioblastoma models of temozolomide chemo-sensitive and resistance by targeting mitochondrial function Cancer Research. 78: 873-873. DOI: 10.1158/1538-7445.Am2018-873  0.424
2018 Awate P, Dadali T, Ng R, Mogre S, Diers AR, Rockwell H, McDaniel J, Chen E, Gao F, Kiebish M, Gesta S, Vishnudas V, Narain NR, Sarangarajan R. Abstract 3530: Coenzyme Q10 (BPM31510-IV in clinical trials) increases mitochondrial Q-pool and modulates electron transport chain function to elicit cell death in pancreatic cancer cells Cancer Research. 78: 3530-3530. DOI: 10.1158/1538-7445.Am2018-3530  0.4
2017 Nagpal S, Dadali T, Jang T, Merchant M, Diers AR, Gesta S, Stevens J, Wilson M, Vishnudas V, Kiebish M, Akmaev VR, Narain NR, Sarangarajan R, Recht LD. Effect of BPM31510 on radiosensitivity of temozolomide-resistant glioblastoma cell model and survival in in vivo C6 glioma rat model supporting phase I clinical investigation in GBM. Journal of Clinical Oncology. 35: e13509-e13509. DOI: 10.1200/Jco.2017.35.15_Suppl.E13509  0.41
2017 Kazerounian S, Sarma A, Gaur N, Nastke MD, Dadali T, Diers AR, Gesta S, Vishnudas VK, Sarangarajan R, Narain NR. Abstract 5576: BPM 31510, a clinical stage candidate demonstrates potent anti-tumor effect in an immune-competent syngeneic pancreatic cancer model Cancer Research. 77: 5576-5576. DOI: 10.1158/1538-7445.Am2017-5576  0.454
2017 Gesta S, Nagpal S, Dadali T, Merchant M, Jan T, Diers AR, Kiebish M, Jiminez J, Vishnudas VK, Narain NR, Sarangarajan R, Recht L. Abstract 4067: BPM31510, a clinical stage metabolic modulator demonstrates therapeutic efficacy in anin vivoC6 rat glioma model and synergizes with temozolomide Cancer Research. 77: 4067-4067. DOI: 10.1158/1538-7445.Am2017-4067  0.4
2017 Dadali T, Krumova K, Diers AR, Awate P, Ng R, Lee A, Gesta S, Vishnudas VK, Sarangarajan R, Narain NR. Abstract 1497: BPM31510 modulates mitochondrial complex activity to influence oxidative stress in effectuating cell death in multiple cancers Cancer Research. 77: 1497-1497. DOI: 10.1158/1538-7445.Am2017-1497  0.449
2016 Botta D, Dadali T, Mousseau BJ, Zhou F, Schultz MD, Zumaquero E, Manouvakhova A, Sosa MI, McKellip SN, Woods L, Tower NA, Ross LJ, Rasmussen L, White EL, Padmalayam I, et al. Abstract LB-055: High-throughput screening efforts for the identification of selective and potent inhibitors of CD38 for the treatment of hematological cancers Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-055  0.609
2016 Dadali T, Diers AR, Ouro-Djobo R, Bourdelais J, Benaim E, Jambhekar B, Walshe TE, Vishnudas VK, Jimenez JJ, Sarangarajan R, Narain NR. Abstract 212: BPM 31510 synergizes gemcitabine efficacy in pancreatic adenocarcinoma via mechanism independent of its anti-Warburg influence on metabolism Cancer Research. 76: 212-212. DOI: 10.1158/1538-7445.Am2016-212  0.457
2016 Dadali T, Diers AR, Lee A, Benaim E, Jimenez JJ, Gesta S, Vishnudas VK, Sarangarajan R, Narain NR. Abstract 208: BPM 31510-induced alteration in Complex II activity is functionally linked to cell death activation pathway in a preclinical model of triple-negative breast cancer Cancer Research. 76: 208-208. DOI: 10.1158/1538-7445.Am2016-208  0.421
2016 Jambhekar B, Dadali T, Diers AR, Gao F, Rockwell H, Chen E, Gesta S, Vishnudas VK, Kiebish MA, Narain NR, Sarangarajan R. Abstract 1014: The anti-Warburg agent BPM 31510 arbitrates fatty acid metabolism in eliciting an anticancer response Cancer Research. 76: 1014-1014. DOI: 10.1158/1538-7445.Am2016-1014  0.428
2015 Blacher E, Dadali T, Bespalko A, Haupenthal VJ, Grimm MO, Hartmann T, Lund FE, Stein R, Levy A. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model. Annals of Neurology. 78: 88-103. PMID 25893674 DOI: 10.1002/Ana.24425  0.555
2015 Botta D, Dadali T, Mousseau B, Manouvakhova A, Sosa MI, MKellip SN, Woods L, Tower NA, Ross LJ, Rasmussen L, White EL, Bostwick JR, Lund FE. Abstract 1242: Modulating the cellular redox state by targeting the NAD glycohydrolase CD38: A novel therapeutic approach for chemosensitizing B-cell malignancies Cancer Research. 75: 1242-1242. DOI: 10.1158/1538-7445.Am2015-1242  0.618
Show low-probability matches.